Skip to main content
Clinical Trials/NCT01829529
NCT01829529
Completed
Phase 3

Susceptibility Changes Among Oral Microorganisms Following Single Dose Antibiotic Prophylaxis

Bodil Lund1 site in 1 country29 target enrollmentSeptember 2013
ConditionsHealthy
InterventionsAmoxicillin

Overview

Phase
Phase 3
Intervention
Amoxicillin
Conditions
Healthy
Sponsor
Bodil Lund
Enrollment
29
Locations
1
Primary Endpoint
Quantitative and qualitative changes in the oral microflora will be determined as well as changes is susceptibility to amoxicillin among these commensals.
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The hypothesis of the present study is that quantitative and qualitative oral microflora alterations and changes in antibiotic susceptibility among oral commensal microflora will occur following a single dose administration of amoxicillin.

Detailed Description

A total of 33 healthy volunteers, 16 males and 17 females, will be included. Written informed consent will be obtained from all participants. Subjects will be excluded if they have taken antibiotics within the previous three months, are pregnant, breast-feeding or allergic against penicillin. The participants will be given a single dose of 2 g amoxicillin. Saliva samples will be collected before administration of antibiotics (day 1) and on day 2, 5, 10, 17 and 24. Un-stimulated saliva will be accumulated in a plastic container. Concentration of amoxicillin in saliva will be measured on day 1, 2 and 5. Samples will be used for the determination of antibiotic concentration. Analyses of the sensitivities to amoxicillin and some other clinically relevant antibiotic compounds will also be performed.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
January 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Bodil Lund
Responsible Party
Sponsor Investigator
Principal Investigator

Bodil Lund

Assoc. professor, Dentist

Karolinska University Hospital

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Age 18-45
  • Understands the study procedure and speaks Swedish and/or English

Exclusion Criteria

  • Treatment with antibiotics within the previous three months
  • Breast-feeding
  • Allergic against penicillin
  • Concomitantly participate in another medical product study
  • Treatment with any kind of medication, health food preparations or probiotics

Arms & Interventions

Amoxicillin

All subjects receive one dose of 2 g Amoxicillin

Intervention: Amoxicillin

Outcomes

Primary Outcomes

Quantitative and qualitative changes in the oral microflora will be determined as well as changes is susceptibility to amoxicillin among these commensals.

Time Frame: Day 1, 2, 5, 10, 17 and 24

Secondary Outcomes

  • Concentration of amoxicillin in saliva after one dose administration of amoxicillin(Day 1, 2, 5)

Study Sites (1)

Loading locations...

Similar Trials